Journal of Chinese Integrative Medicine ›› 2004, Vol. 2 ›› Issue (2): 86-89.doi: 10.3736/jcim20040203
• Expert Forum • Previous Articles Next Articles
Chang-quan Ling
[1] | 印会河 . 中医基础理论(第1版)[M]. 上海: 上海科学技术出版社, 1984,( 第1版):8 |
[2] |
申维玺 . 论中医“证”的现代医学属性和概念[J]. 中医杂志, 2001,42(5):307-309
doi: 10.3321/j.issn:1001-1668.2001.05.028 |
[3] |
张立华, 高学功 . 中医“证”与“辨证”之浅见[J]. 时珍国医国药, 2002,13(7):412-413
doi: 10.3969/j.issn.1008-0805.2002.07.016 |
[4] | 沈自尹 . 我的科研历程和思考[J]. 中医杂志, 2000,41(11):690-692 |
[5] | 邓铁涛 . 中医诊断学(第1版)[M]. 上海: 上海科学技术出版社, 1984,( 第1版):118 |
[6] | 金益强 . 中医肝脏象现代研究与临床(第1版)[M]. 北京: 人民卫生出版社, 2000,( 第1版):241 |
[7] | .[ 国家技术监督局.中华人民共和国国家标准——中医临床诊疗术语证候部分[S]. 北京: 中国标准出版社,1997.30. |
[8] | 任占利, 郭蓉娟 . 中风病证候诊断标准的研究[J]. 北京中医药大学学报, 1996,19(4):49-50 |
[9] | 吴大嵘, 梁伟雄, 温泽淮 , 等. 建立中风病血瘀证宏观辨证量化标准的方法探讨[J]. 广州中医药大学学报, 1999,16(4):249-252 |
[10] | 邱向红 . 脾虚证计量诊断的探讨[J]. 广州中医学院学报, 1990,7(1):24-27 |
[11] | 寺泽捷年 ( 陈可冀等译).瘀血证的证候分析与诊断标准刍议[J]. 国外医学·中医中药分册, 1984,6(1):1 |
[12] |
侯风刚, 赵钢, 沈旭波 , 等. 原发性肝癌中医单证证型专家观点文献分析[J]. 南京中医药大学学报, 2003,19(4):244-246
doi: 10.3969/j.issn.1000-5005.2003.04.021 |
[1] | Wan-jun Guo, Yi Wang, Yu Deng, Lin-yan Cheng, Xin Liu, Ruo-fan Xi, Sheng-jie Zhu, Xin-yi Feng, Liang Hua, Kan Ze, Jian-yong Zhu, Dong-jie Guo, Fu-lun Li. Therapeutic effects of the extract of Sancao Formula, a Chinese herbal compound, on imiquimod-induced psoriasis via cysteine-rich protein 61. Journal of Integrative Medicine, 2022, 20(4): 376-384. |
[2] | Shang-jin Song, Xuan Liu, Qing Ji, Da-zhi Sun, Li-juan Xiu, Jing-yu Xu, Xiao-qiang Yue. Ziyin Huatan Recipe, a Chinese herbal compound, inhibits migration and invasion of gastric cancer by upregulating RUNX3 expression. Journal of Integrative Medicine, 2022, 20(4): 355-364. |
[3] | Marisa Casal. Improving the health and treatment success rates of in vitro fertilization patients with traditional chinese medicine: need for more robust evidence and innovative approaches. Journal of Integrative Medicine, 2022, 20(3): 187-192. |
[4] | Ning Guo, Fei Wu, Mei Wu, Yuan Wang, Qing Lang, Xiao Lin, Yi Feng. Progress in the design and quality control of placeboes for clinical trials of traditional Chinese medicine . Journal of Integrative Medicine, 2022, 20(3): 204-212. |
[5] | Yan-jun Lin, Kun-li Jiao, Bo Liu, Lu Fang, Shu Meng. Antiplatelet and myocardial protective effect of shexiang tongxin dropping pill in patients undergoing percutaneous coronary intervention: A randomized controlled trial. Journal of Integrative Medicine, 2022, 20(2): 126-134. |
[6] | Jia-jia Li, Qing Liang, Guang-chun Sun. Traditional Chinese medicine for prevention and treatment of hepatocellular carcinoma: A focus on epithelial-mesenchymal transition. Journal of Integrative Medicine, 2021, 19(6): 469-477. |
[7] | Rui-jin Qiu, Min Li, Jia-yuan Hu, Jing Chen, Hong-cai Shang. Methods for development of a core outcome set for clinical trials integrating traditional Chinese medicine and Western medicine. Journal of Integrative Medicine, 2021, 19(5): 389-394. |
[8] | Mao-xing Pan, Chui-yang Zheng, Yuan-jun Deng, Kai-rui Tang, Huan Nie, Ji-qian Xie, Dong-dong Liu, Gui-fang Tu, Qin-he Yang, Yu-pei Zhang. Hepatic protective effects of Shenling Baizhu powder, a herbal compound, against inflammatory damage via TLR4/NLRP3 signalling pathway in rats with nonalcoholic fatty liver disease . Journal of Integrative Medicine, 2021, 19(5): 428-438. |
[9] | Ning Zhang, Xiao-he Xiao. Integrative medicine in the era of cancer immunotherapy: Challenges and opportunities. Journal of Integrative Medicine, 2021, 19(4): 291-294. |
[10] | Thomas Efferth, An-long Xu, Roxana Damiescu, Mita Banerjee, Norbert W. Paul, David Y.W. Lee. Can eastern wisdom resolve western epidemics? Traditional chinese medicine therapies and the opioid crisis. Journal of Integrative Medicine, 2021, 19(4): 295-299. |
[11] | Si-qi Tang, Yun-liang Wang, Zi-ye Xie, Yang Zhang, Yi Guo, Kang-li Gao, Tang-you Mao, Chun-e Xie, Jun-xiang Li, Xiao-yan Gao. Serum metabolic profiling of traditional Chinese medicine syndromes in patients with diarrhea-predominant irritable bowel syndrome. Journal of Integrative Medicine, 2021, 19(3): 274-281. |
[12] | Miao-yan Shi, Shi-qi Sun, Wei Zhang, Xing Zhang, Gui-hua Xu, Xuan Chen, Zi-jian Su, Xiu-ming Song, Lu-jiong Liu, Yi-bao Zhang, Yi-le Zhang, Meng Sun, Qi Chen, Yan Xue, Hua Lü, Wei-an Yuan, Xiao-rong Chen, Yun-fei Lu. Early therapeutic interventions of traditional Chinese medicine in COVID-19 patients: a retrospective cohort study. Journal of Integrative Medicine, 2021, 19(3): 226-231. |
[13] | Shu-jun Wei, Qing-man He, Qing Zhang, Kang-hua Fu, Ruo-lan Li, Wei Peng, Yong-xiang Gao. Traditional Chinese medicine is a useful and promising alternative strategy for treatment of Sjogren's syndrome: A review. Journal of Integrative Medicine, 2021, 19(3): 191-202. |
[14] | Yi Xia, Lu-shao-bo Shi, Jing-hui Chang, Hua-zhang Miao, Dong Wang. Impact of the COVID-19 pandemic on intention to use traditional Chinese medicine: A cross-sectional study based on the theory of planned behavior. Journal of Integrative Medicine, 2021, 19(3): 219-225. |
[15] | Na Zhi, Qian Mo, Shuo Yang, Yuan-xing Qin, Hao Chen, Zeng-guang Wu, Cai-hong Lan, Jun Zhang, Yin-long Li. Treatment of pulmonary fibrosis in one convalescent patient with corona virus disease 2019 by oral traditional Chinese medicine decoction: A case report. Journal of Integrative Medicine, 2021, 19(2): 185-190. |